CDRH Transparency Update

You are subscribed to CDRH Transparency for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

Evaluation of Automatic Class III Designation (De Novo) Summaries

•  Neuropsychiatric EEG-Based Assessment Aid for ADHD (NEBA) System - K112711

 

CDRH Transparency home page

 

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420